评论",活体内脑膜瘤中针对德西他的瘤基因表达"
Hethesh Chellapandian1, Sivakamavalli Jeyachandran2
1Lab in Biotechnology and Biosignal Transduction, Department of Orthodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai-77, Tamil Nadu, India.
这项研究研究了在脑膜瘤中针对德西他的瘤基因. 升高的ELOVL2表达与瘤复发相关,这表明了德西他.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 脑膜瘤是脑膜的瘤,高度变异缺乏有效的治疗方法.
- 低甲基化剂decitabine针对癌症发展相关的特定瘤基因.
- 了解癌基因表达对于开发耐火性脑膜瘤的向疗法至关重要.
研究的目的:
- 为了探索在脑膜瘤中表达基因向基因 (TRIM58,FAM84B,ELOVL2,DIO3) 的表达.
- 评估在高度脑膜瘤中西的治疗潜力.
- 为了将瘤基因表达与瘤等级和复发相关联.
主要方法:
- 对100多名患者脑膜瘤样本的分析.
- 免疫组织化学染色以评估蛋白质表达.
- 逆转录-聚合酶链反应 (RT-PCR) 用于基因表达分析.
主要成果:
- 在癌基因表达和脑膜瘤瘤等级之间发现了显著的相关性.
- 提高ELOVL2的表达显著与瘤复发的增加有关.
- 德西塔在脑膜瘤细胞中调节瘤基因表达方面表现出潜力.
结论:
- 德西塔作为耐火性脑膜瘤的治疗剂具有前景.
- 瘤基因表达模式,特别是ELOVL2,是脑膜瘤行为的重要指标.
- 需要对更大的队列和先进的基因组技术进行进一步的研究,以阐明瘤机制和decitabine的疗效.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
相关概念视频
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
